A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) …

B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - Vaccine, 2012 - Elsevier
BACKGROUND: Increasing incidence of pertussis in adolescents and adults has stimulated
the development of safe and immunogenic acellular pertussis vaccines for booster …
被引用次数：41 相关文章

A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) …

B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - Vaccine, 2012 - infona.pl
Increasing incidence of pertussis in adolescents and adults has stimulated the development
of safe and immunogenic acellular pertussis vaccines for booster vaccination of adolescents …

A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) …

B Thierry-Carstensen, K Jordan, HH Uhlving… - …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Increasing incidence of pertussis in adolescents and adults has stimulated the
development of safe and immunogenic acellular pertussis vaccines for booster vaccination …

A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) …

B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - Vaccine, 2012 - europepmc.org
Background Increasing incidence of pertussis in adolescents and adults has stimulated the
development of safe and immunogenic acellular pertussis vaccines for booster vaccination …

[引用][C] A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP …

B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - Vaccine, 2012 - research.regionh.dk
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a
tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to …

A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) …

B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - Vaccine, 2012 - hero.epa.gov
BACKGROUND: Increasing incidence of pertussis in adolescents and adults has stimulated
the development of safe and immunogenic acellular pertussis vaccines for booster …

A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) …

B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - 2012 - cabidigitallibrary.org
Background: Increasing incidence of pertussis in adolescents and adults has stimulated the
development of safe and immunogenic acellular pertussis vaccines for booster vaccination …

[引用][C] A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP …

B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - 2012

[引用][C] A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP …

B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - Vaccine, 2012 - Elsevier Limited